Filing Details

Accession Number:
0001209191-18-024046
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-04-05 16:14:43
Reporting Period:
2018-04-03
Accepted Time:
2018-04-05 16:14:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1488613 Foundation Medicine Inc. FMI () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1402017 J Michael Pellini 150 Second Street
C/O Foundation Medicine, Inc.
Cambridge MA 02141
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-04-03 13,659 $70.28 114,211 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2017.
  2. The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.95 to $73.35, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.